Check out our most popular compounded medications! Get Started
The Gabapentin 5%/Ketoprofen 5%/Lidocaine 5%/Pentoxifylline 5% Transdermal Gel is a compounded medication designed for topical application. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise dosing. The gel consistency ensures that the medication is spread evenly on the skin, optimizing the absorption of the active ingredients.
This multi-ingredient gel is commonly used in the management of various disease states, including neuropathic pain, inflammatory conditions, and certain circulatory disorders. Gabapentin is included for its role in reducing neuropathic pain, while Ketoprofen serves as a nonsteroidal anti-inflammatory drug (NSAID) to alleviate inflammation and pain. Lidocaine, a local anesthetic, provides immediate topical pain relief. Lastly, Pentoxifylline is incorporated for its vasodilatory effects, which can improve blood flow in peripheral vascular diseases.
The combination of these four active ingredients in a single transdermal gel allows for a multimodal approach to pain management and treatment of associated symptoms in conditions such as diabetic neuropathy, arthritis, and intermittent claudication associated with peripheral artery disease.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Our custom-compounded transdermal gel combines Gabapentin, Ketoprofen, Lidocaine, and Pentoxifylline, each at a concentration of 5%, to create a potent formulation designed for targeted relief of various conditions. This semisolid preparation is dispensed through a pump mechanism, which ensures ease of use and precise dosing. The gel base allows for the active ingredients to be absorbed through the skin, directly reaching the affected area.
Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic and anti-inflammatory effects, making it useful for conditions such as arthritis or soft tissue injuries. Lidocaine, a local anesthetic, offers immediate relief from pain by numbing the area of application. Lastly, Pentoxifylline is a xanthine derivative that improves blood flow and has been used in the treatment of muscle pain and claudication associated with certain circulatory conditions.
The combination of these four active ingredients in a transdermal gel allows for a multimodal approach to pain management. The anti-inflammatory properties of Ketoprofen, the nerve pain relief from Gabapentin, the local anesthetic effect of Lidocaine, and the circulation enhancement from Pentoxifylline work synergistically. This can be particularly beneficial for patients suffering from complex regional pain syndromes, diabetic neuropathy, or other conditions where multiple mechanisms of pain are present.
For patients and prescribers considering this formulation, it is important to note that transdermal delivery can minimize systemic side effects and provide localized relief. However, as with any medication, there may be potential side effects or interactions, and it is essential to use this medication under the guidance of a healthcare professional. The specific dose and frequency of application will depend on the individual patient's condition and response to therapy.
If you have any questions or require further information about this custom-compounded transdermal gel, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of our formulations.
The transdermal gel formulation containing Gabapentin, Ketoprofen, Lidocaine, and Pentoxifylline is designed for topical application and may offer localized relief from pain and inflammation. However, it is important to consider potential drug interactions, especially if the patient is taking other systemic medications or applying other topical treatments. Gabapentin, while primarily used for neuropathic pain, may interact with antacids containing aluminum or magnesium, potentially reducing the absorption of gabapentin. Caution is advised when co-administered with central nervous system (CNS) depressants, as gabapentin can potentiate the effects of sedatives, hypnotics, and opioids.
Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can increase the risk of bleeding when combined with other drugs that affect coagulation, such as warfarin, heparin, or other NSAIDs. It may also interact with anti-hypertensive medications and diuretics, potentially diminishing their effects. Monitoring blood pressure is recommended when using this formulation in patients on anti-hypertensive therapy. Additionally, concurrent use with other topical products containing NSAIDs should be avoided to prevent excessive systemic absorption and toxicity.
Lidocaine, a local anesthetic, may interact with other local anesthetics or class I antiarrhythmic drugs (such as tocainide and mexiletine), leading to additive systemic effects. Caution is advised when used with other medications that may increase methemoglobin levels, such as nitrates or certain antibiotics. Patients with hepatic impairment should be monitored closely, as lidocaine metabolism is hepatically mediated.
Pentoxifylline, a xanthine derivative, is used to improve blood flow and may potentiate the effects of antihypertensive agents and anticoagulants, increasing the risk of bleeding. It should be used with caution in patients taking blood thinners or those with a history of bleeding disorders. Additionally, concurrent use of CYP1A2 inhibitors, such as fluvoxamine or ciprofloxacin, may increase pentoxifylline serum levels and the risk of adverse effects.
It is essential to inform patients that while the systemic absorption of these medications in a transdermal gel is lower than oral administration, interactions can still occur. Patients should be advised to provide a complete list of their current medications, including over-the-counter drugs and supplements, to their healthcare provider. This formulation is used to treat conditions such as neuropathic pain, inflammatory conditions, and to improve blood flow in peripheral vascular diseases. If you have any questions or require further information regarding this formulation and its potential interactions, please reach out to us at Bayview Pharmacy.
The Gabapentin 5%/Ketoprofen 5%/Lidocaine 5%/Pentoxifylline 5% Transdermal Gel is a compounded medication designed to deliver active pharmaceutical ingredients directly through the skin to the site of pain or inflammation. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application. The gel-like consistency ensures that the medication stays at the site of application, providing targeted treatment and facilitating the absorption of the active ingredients.
Gabapentin is an anticonvulsant and analgesic drug that is commonly used to treat neuropathic pain. In this transdermal formulation, gabapentin works by modulating the activity of certain neurotransmitters in the skin, which can help to reduce pain signals sent to the brain. Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic and anti-inflammatory effects. When applied topically, ketoprofen can reduce local inflammation and pain without the systemic side effects often associated with oral NSAIDs.
Lidocaine is a local anesthetic that provides temporary relief of pain by blocking nerve signals in the body. In a transdermal gel, lidocaine can help to numb the area of application, providing immediate pain relief. Pentoxifylline is a xanthine derivative that is typically used to improve blood flow. In this formulation, it may help to improve microcirculation at the site of application, potentially enhancing the delivery and efficacy of the other active ingredients.
This combination of gabapentin, ketoprofen, lidocaine, and pentoxifylline in a transdermal gel is particularly useful for treating localized pain conditions, such as neuropathic pain, inflammatory conditions, and certain types of soft tissue injuries. By delivering the medication directly to the affected area, patients may experience quicker relief with fewer systemic side effects. Additionally, the transdermal route bypasses the gastrointestinal system, which can be beneficial for patients who have difficulty tolerating oral medications or for those who wish to avoid gastrointestinal side effects.
It is important for both patients and prescribers to understand that this is a compounded medication and should be used under the guidance of a healthcare professional. The specific concentration of each ingredient has been chosen to maximize therapeutic effects while minimizing the risk of side effects. If you have any questions about this formulation or its appropriateness for a particular patient, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to provide support and answer any questions you may have.
While the primary indication for the compound medication containing Gabapentin, Ketoprofen, Lidocaine, and Pentoxifylline is often related to managing symptoms of peripheral neuropathy, complex regional pain syndrome (CRPS), and various localized chronic pain conditions, this versatile transdermal gel formulation may also have alternate uses. Anecdotal evidence suggests that patients with other types of nerve-related pain, such as postherpetic neuralgia or diabetic neuropathy, may find relief using this combination. The anti-inflammatory properties of Ketoprofen in conjunction with Gabapentin's neuropathic pain relief, Lidocaine's local anesthetic effects, and Pentoxifylline's circulatory enhancements could potentially provide symptomatic relief for these conditions as well.
Additionally, this formulation might be considered for off-label uses where its individual components’ pharmacological properties can be advantageous. For instance, the local analgesic effect of Lidocaine and the anti-inflammatory action of Ketoprofen might be beneficial in conditions involving localized soft tissue inflammation or joint pain, like tendinitis or bursitis. Furthermore, due to Pentoxifylline’s ability to improve blood flow, there is a potential for the gel to be used to treat localized circulatory disorders or even conditions like Raynaud's phenomenon, where improving blood flow can alleviate symptoms. However, such uses would be off-label and require careful consideration and consultation with a healthcare provider.
It is essential for both patients and prescribers to note that while the gabapentin/ketoprofen/lidocaine/pentoxifylline transdermal gel may offer therapeutic benefits in a broad range of conditions, its efficacy in applications other than its primary indications has not been thoroughly studied. Careful patient monitoring for efficacy and safety is always required when using compounded medications for off-label purposes. If considering this formulation for alternative uses, prescribers must weigh the potential benefits against any risks, and patients should be counseled accordingly regarding expected outcomes, potential side effects, and proper usage.
Patients with known hypersensitivities to any of the formulation's components should not use this gel. Additionally, due to its transdermal delivery, there is always a risk of skin irritation or allergic reaction at the application site, and close monitoring for such reactions is prudent. Lastly, as with any compounded medication, this formulation should be used under the tight supervision of a healthcare provider who can monitor patient response and make necessary adjustments to treatment. If you have any questions about the potential uses or considerations for this compounded medication, please reach out to Bayview Pharmacy for professional guidance and support.
This compounded formulation is often prescribed for the management of various types of pain, including neuropathic pain and localized musculoskeletal pain. The combination of Gabapentin, Ketoprofen, Lidocaine, and Pentoxifylline works together to provide analgesic and anti-inflammatory effects, as well as improve blood flow to the affected area.
To use the gel, apply a small amount onto the skin over the affected area as directed by your healthcare provider. The pump mechanism allows for precise dosing, and you should rub the gel in until it is absorbed. Avoid applying near the eyes, mouth, or any open skin wounds.
The frequency of application will depend on your doctor's instructions. It is important to follow the prescribed regimen and not to use more often than recommended in order to prevent potential side effects.
After application, you should wait until the gel has completely dried before covering the area with any bandages or clothing. Consult with your pharmacist if you need to apply a dressing, as some types may be influenced by the ingredients in the gel.
If you miss a dose, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular application schedule. Do not apply extra gel to make up for the missed dose.
Potential side effects may include local skin reactions such as redness, irritation, or itchiness at the application site. Systemic side effects are less common due to topical administration, but they can occur if the medication is absorbed into the bloodstream in significant amounts. Notify your healthcare provider if you experience any unusual symptoms.
This compounded gel may interact with other medications, so it is important to inform your healthcare provider about all the medicines you are taking, including prescription, over-the-counter, and herbal supplements. Your provider will advise you on the safety of using this gel with other treatments.
Store the gel at room temperature, away from heat and direct sunlight. Keep the container tightly closed when not in use. Ensure to keep it out of reach of children and pets.
The shelf life will depend on the compounding pharmacy's guideline and the ingredients used. Typically, compounded medications have a shorter shelf life than commercially available products. Check the label for the expiration date or consult your pharmacist for more information.
If you suspect an overdose or experience severe side effects, seek medical attention immediately. Overdose symptoms might not be immediately apparent due to the transdermal route of administration, but it is essential to act quickly if an overdose is suspected.
This medication may not be suitable for everyone. It should not be used by individuals who are allergic to any of its ingredients or by certain patient populations unless deemed safe by a healthcare provider. Always consult with your primary care provider to determine if this formulation is appropriate for your specific condition.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
